Medifast Company Profile (NYSE:MED)

About Medifast

Medifast logoMedifast, Inc. (Medifast) is engaged in the production, distribution and sale of weight loss, weight management and healthy living products, and other consumable health and diet products. The Company operates through its subsidiaries, Jason Pharmaceuticals, Inc., Take Shape For Life, Inc., Jason Enterprises, Inc., Medifast Franchise Systems (MFSI), Inc., Jason Properties, LLC, Medifast Nutrition, Inc. and Seven Crondall, LLC. Its product lines include weight loss, weight management, and healthy living meal replacements, snacks, hydration products and vitamins. It provides weight loss, weight management and healthy living products and programs through multiple channels of distribution: direct to consumer channel through its Website and in-house call centers; Take Shape For Life; Franchise Medifast Weight Control Centers, and a national network of physicians. It offers its products under the Medifast, Thrive by Medifast, Optimal Health by Take Shape For Life and Essential 1 brands.

Industry, Sector and Symbol:
  • Sector: Consumer Staples
  • Industry: Specialty Retail, Other
  • Sub-Industry: Personal Products
  • Exchange: NYSE
  • Symbol: MED
  • CUSIP: 58470H10
Key Metrics:
  • Previous Close: $41.02
  • 50 Day Moving Average: $38.52
  • 200 Day Moving Average: $34.95
  • 52-Week Range: $27.12 - $42.14
  • Trailing P/E Ratio: 28.79
  • Foreward P/E Ratio: 21.04
  • P/E Growth: 1.28
  • Market Cap: $486.00M
  • Outstanding Shares: 11,848,000
  • Beta: 0.65
  • Net Margins: 6.29%
  • Return on Equity: 24.46%
  • Return on Assets: 18.59%
  • Current Ratio: 4.02%
  • Quick Ratio: 3.55%
Additional Links:
Companies Related to Medifast:

Analyst Ratings

Consensus Ratings for Medifast (NYSE:MED) (?)
Ratings Breakdown: 2 Hold Ratings, 1 Buy Rating
Consensus Rating:Hold (Score: 2.33)
Consensus Price Target: $34.67 (15.49% downside)

Analysts' Ratings History for Medifast (NYSE:MED)
DateFirmActionRatingPrice TargetDetails
8/4/2016WunderlichBoost Price TargetHold$32.00 -> $36.00View Rating Details
1/11/2016SidotiUpgradeNeutral -> Buy$35.00View Rating Details
11/8/2015Canaccord GenuityReiterated RatingHold$33.00View Rating Details
11/7/2014Imperial CapitalDowngradeOutperform -> In-Line$34.00 -> $32.00View Rating Details
(Data available from 10/27/2014 forward)


Earnings History for Medifast (NYSE:MED)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/3/2016Q216$0.51$0.63$72.01 million$71.14 millionViewN/AView Earnings Details
5/4/2016Q116$0.33$0.42$69.31 million$72.30 millionViewN/AView Earnings Details
3/10/2016Q415$0.35$0.33$62.98 million$61.30 millionViewListenView Earnings Details
11/5/2015Q315$0.42$0.45$67.00 million$65.90 millionViewN/AView Earnings Details
8/5/2015Q215$0.48$0.48$72.79 million$72.20 millionViewN/AView Earnings Details
5/7/2015Q115$0.35$0.46$71.80 million$73.30 millionViewN/AView Earnings Details
3/12/2015Q414$0.46$0.38$69.40 million$62.30 millionViewN/AView Earnings Details
11/5/2014Q314$0.36$0.47$76.10 million$74.00 millionViewN/AView Earnings Details
8/7/2014Q114$0.39$0.44$87.30 million$80.88 millionViewN/AView Earnings Details
5/5/2014Q1$0.37$0.45$87.60 million$86.50 millionViewN/AView Earnings Details
3/10/2014Q413$0.36$0.39$80.83 million$77.30 millionViewN/AView Earnings Details
11/5/2013Q313$0.42$0.41$95.07 million$86.48 millionViewN/AView Earnings Details
8/6/2013Q2 2013$0.51$0.51$101.30 million$97.10 millionViewN/AView Earnings Details
5/8/2013Q1 2013$0.34$0.43$93.77 million$96.00 millionViewN/AView Earnings Details
3/7/2013Q4 2012$0.25$0.28$82.90 million$83.20 millionViewN/AView Earnings Details
11/5/2012Q312$0.40$0.42$89.73 million$91.00 millionViewN/AView Earnings Details
7/26/2012$0.38$0.47ViewN/AView Earnings Details
5/8/2012$0.38$0.29ViewN/AView Earnings Details
3/13/2012$0.21$0.08ViewN/AView Earnings Details
11/3/2011$0.38$0.36ViewN/AView Earnings Details
8/4/2011$0.47$0.41ViewN/AView Earnings Details
5/9/2011$0.41$0.44ViewN/AView Earnings Details
3/31/2011$0.32$0.23ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Medifast (NYSE:MED)
Current Year EPS Consensus Estimate: $1.82 EPS
Next Year EPS Consensus Estimate: $1.95 EPS


Current Dividend Information for Medifast (NYSE:MED)
Annual Dividend:$1.00
Dividend Yield:2.44%
Dividend Growth:0.00% (3 Year Average)
Payout Ratio:69.44% (Based on Trailing 12 Months of Earnings)
54.95% (Based on Current Year Consensus EPS Estimate)
51.28% (Based on Next Year Consensus EPS Estimate)

Dividend History for Medifast (NYSE:MED)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Medifast (NYSE:MED)
Insider Ownership Percentage: 6.47%
Institutional Ownership Percentage: 87.37%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/31/2016Balanced Master Fund L VisiumMajor ShareholderSell1,350,000$30.25$40,837,500.00View SEC Filing  
4/1/2016Margaret SheetzCOOSell8,333$30.02$250,156.66View SEC Filing  
2/1/2016Margaret SheetzCOOSell8,333$28.62$238,490.46View SEC Filing  
12/1/2015Margaret SheetzCOOSell8,333$29.92$249,323.36View SEC Filing  
11/2/2015Margaret SheetzCOOSell8,333$28.72$239,323.76View SEC Filing  
10/5/2015Margaret SheetzCOOSell8,333$28.88$240,657.04View SEC Filing  
9/3/2015Margaret SheetzCOOSell6,864$28.00$192,192.00View SEC Filing  
9/2/2015Margaret SheetzCOOSell1,469$28.00$41,132.00View SEC Filing  
6/25/2015Moduslink Global Solutions IncMajor ShareholderSell29,654$33.03$979,471.62View SEC Filing  
6/23/2015Moduslink Global Solutions IncMajor ShareholderSell27,443$33.01$905,893.43View SEC Filing  
6/22/2015Moduslink Global Solutions IncMajor ShareholderSell9,494$33.01$313,396.94View SEC Filing  
6/11/2015Barry B BondroffDirectorSell1,666$31.88$53,112.08View SEC Filing  
6/10/2015Margaret SheetzCOOSell8,337$32.00$266,784.00View SEC Filing  
6/4/2015John P McdanielDirectorSell3,000$32.14$96,420.00View SEC Filing  
8/18/2014Jeannette M MillsEVPSell3,000$28.03$84,090.00View SEC Filing  
6/10/2014Jason L GrovesEVPSell3,250$31.75$103,187.50View SEC Filing  
6/10/2014John P McdanielDirectorSell3,500$31.74$111,090.00View SEC Filing  
6/9/2014Jeannette M MillsEVPSell2,784$32.09$89,338.56View SEC Filing  
6/5/2014Charles P ConnollyDirectorSell7,500$30.91$231,825.00View SEC Filing  
12/2/2013Margaret Macdonald SheetzCOOSell18,000$25.63$461,340.00View SEC Filing  
11/22/2013Margaret Macdonald SheetzCOOSell35,000$24.33$851,550.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Medifast (NYSE:MED)
DateHeadline logoMedifast Up 21.3% Since SmarTrend Uptrend Call (MED) (NYSE:MED) - October 26 at 6:09 PM logoMedifast Inc (NYSE:MED) Files An 8-K (NYSE:MED) - October 18 at 11:21 AM logoForm 8-K MEDIFAST INC For: Oct 17 (NYSE:MED) - October 17 at 6:02 PM logoMEDIFAST INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits (NYSE:MED) - October 17 at 11:07 AM logoStock is up at $39.47 (MED) Medifast, Inc. to Announce Financial… (NYSE:MED) - October 12 at 6:02 PM logoMedifast, Inc. to Announce Financial Results for the Third Quarter Ended September 30, 2016 (NYSE:MED) - October 12 at 6:02 PM
News IconMedifast Names Direct Sales Veteran Daniel Chard As CEO (NYSE:MED) - October 6 at 5:55 PM logoMedifast's CEO big stock price goals may mean international push (NYSE:MED) - October 6 at 5:55 PM logoMedifast, Inc. (NYSE:MED) Files An 8-k (NYSE:MED) - October 6 at 5:55 PM logoBRIEF-Medifast announces appointment of Daniel Chard as CEO (NYSE:MED) - October 5 at 5:58 PM logoMedifast (MED) Names Daniel R. Chard as CEO; Company Sees Meeting or Exceeding Q3 Guidance (NYSE:MED) - October 5 at 5:58 PM
News IconMedifast names new CEO, grants signing bonus (NYSE:MED) - October 5 at 5:58 PM
News IconMedifast elects Daniel R. Chard as chief executive officer (NYSE:MED) - October 5 at 5:58 PM
News IconMedifast replaces CEO with industry veteran (NYSE:MED) - October 5 at 5:58 PM logoMEDIFAST INC Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure, Financial State (NYSE:MED) - October 5 at 11:12 AM logoMedifast's MacDonald out as CEO (NYSE:MED) - October 4 at 10:52 AM logoMedifast, Inc. Announces Appointment of Direct Selling Industry Veteran Daniel R. Chard as Chief Executive Officer (NYSE:MED) - October 3 at 5:47 PM logoMedifast, Inc. Announces Appointment of Direct Selling Industry Veteran Daniel R. Chard as Chief Executive Officer (NYSE:MED) - October 3 at 5:47 PM logoMEDIFAST INC : ex-dividend day (NYSE:MED) - September 21 at 5:48 PM logoMedifast declares $0.25 dividend (NYSE:MED) - September 8 at 5:13 PM
News IconArmy Inks Agreement with Play By Play Sports (NYSE:MED) - September 7 at 6:15 PM
News IconIndustry Opportunities for Weight Loss Services and Management Market (NYSE:MED) - August 30 at 6:06 PM logoETF’s with exposure to Medifast, Inc. : August 19, 2016 (NYSE:MED) - August 19 at 6:03 PM logoWeight Loss Services Market - Recent industry trends and developments (NYSE:MED) - August 18 at 6:14 PM
News IconHow to Use Your Judaism to Lose Weight (NYSE:MED) - August 15 at 6:19 PM
News IconHow to Stay Fit on Vacation (NYSE:MED) - August 11 at 6:29 PM logoMedifast, Inc. :MED-US: Earnings Analysis: Q2, 2016 By the Numbers : August 10, 2016 (NYSE:MED) - August 10 at 6:33 PM logoMEDIFAST INC Files SEC form 10-Q, Quarterly Report (NYSE:MED) - August 9 at 6:22 PM logoMedasys SA :MED-FR: Earnings Analysis: For the six months ended December 31, 2015 : August 8, 2016 (NYSE:MED) - August 8 at 10:49 AM logoMedifast posts 2Q profit (NYSE:MED) - August 4 at 9:17 AM logoMedifast profit drops 45 percent in 2Q (NYSE:MED) - August 4 at 9:17 AM logoEdited Transcript of MED earnings conference call or presentation 3-Aug-16 8:30pm GMT (NYSE:MED) - August 4 at 9:17 AM
News IconMedifast sees growth in largest division, but overall revenue down in 2Q (NYSE:MED) - August 3 at 6:30 PM logoMedifast Inc.: Medifast, Inc. Announces Second Quarter 2016 Financial Results (NYSE:MED) - August 3 at 6:30 PM logoMEDIFAST INC Files SEC form 8-K, Results of Operations and Financial Condition (NYSE:MED) - August 3 at 6:29 PM logoMedifast, Inc. Announces Second Quarter 2016 Financial Results (NYSE:MED) - August 3 at 6:29 PM logo4:25 pm Medifast beats by $0.12, misses on revs; guides Q3 below two analyst estimate; raises FY16 EPS gudiance, reaffirms FY16 revs guidance (NYSE:MED) - August 3 at 6:29 PM logoBRIEF-Medifast raises FY adjusted earnings from cont ops forecast (NYSE:MED) - August 3 at 5:42 PM logoWeight Management Market: Rising Awareness, Competition Significant Growth Factors (NYSE:MED) - August 3 at 9:26 AM logoQ2 2016 Medifast Inc Earnings Release - After Market Close (NYSE:MED) - August 3 at 9:26 AM logoFood Stocks Earnings Lined Up for Aug 3: MED, MGPI & OME (NYSE:MED) - August 2 at 10:57 AM
News IconScentsy hires three new vice presidents (NYSE:MED) - August 1 at 10:50 AM logoMedifast unveils a new product line for its biggest division (NYSE:MED) - July 28 at 6:22 AM logoTake Shape For Life® Introduces Exclusive Product Line Under New OPTAVIA™ Lifestyle Brand (NYSE:MED) - July 25 at 8:08 AM logoMedifast : Take Shape for Life launches Optavia branded products (NYSE:MED) - July 24 at 10:25 AM
News IconWeight loss company Medifast launches new products under Optavia brand (NYSE:MED) - July 22 at 6:01 PM logoMedifast : Weight loss company Medifast launches new products under Optavia brand (NYSE:MED) - July 22 at 6:01 PM
News IconMedifast to release 2Q earnings report Aug. 3 (NYSE:MED) - July 12 at 6:24 PM logoMedifast, Inc. to Announce Financial Results for the Second Quarter Ended June 30, 2016 (NYSE:MED) - July 12 at 8:23 AM logoWeight Loss Services Market set to Grow in Coming Years; Driven by Huge Consumer Base-Transparency Market Research (NYSE:MED) - July 11 at 10:48 AM


Medifast (NYSE:MED) Chart for Thursday, October, 27, 2016

Last Updated on 10/27/2016 by Staff